Bio-Identical Hormone Replacement Therapy (Bio HRT) Now Available at FemaleMedCare.Com
Posted on: Wednesday, 16 August 2006, 15:00 CDT
KISSIMMEE, Fla., Aug. 16 /PRNewswire/ -- Hormone replacement therapy (HRT) is a system of medical treatment for perimenopausal, menopausal, and postmenopausal women, designed to reduce discomfort and health problems caused by diminished circulating estrogen hormones. This treatment involves administering hormones such as estrogens, progesterone or progestins to boost the patient's hormone levels.
Traditionally, the most commonly prescribed forms of HRT have been proprietary mixtures, combining synthetic and equine estrogens rather than bio-identical human estrogens, and have favored the use of progestins, rather than the human form of progesterone.
Lately, an increasing number of studies have shown that certain risks are associated with these combinations of progestins and equine estrogens, and these studies have caused many women to forgo the benefits of HRT to avoid the possible negative health effects.
It is very important to note, that the overwhelming majority of studies which have found adverse health effects were studies of only equine and synthetic estrogens and progestins, but have been reported in the media as generalized studies of estrogen or progesterone.
In contrast to the aforementioned synthetic/equine blends, bio-identical forms of human estrogen and progesterone therapy (Bio HRT) have been studied little, and the results of studies involving synthetic hormones cannot be accurately applied to Bio HRT.
Bio HRT is therapy utilizing hormone replacements that have usually been produced from plant sources, to match the naturally occurring human estrogens, estradiol and estriol, as well as progesterone, and sometimes testosterone. Bio-identical hormones have also been called "natural" hormones, because of their biological similarity to those found in the human body.
Additionally, Bio HRT often is delivered via the topical administration of a cream or gel solution to the skin, reducing concerns about liver effects.
All of this adds up to good news for the millions of women who desperately need the relief of hormone therapy, but who fear the potential adverse health effects of traditional HRT. They now have an effective, but safer alternative.
For additional information on the news that is the subject of this release, please contact FemaleMedCare customer service, at 1-800-928-3134, or visit http://www.femalemedcare.com/.
About FemaleMedCare, LLC
FemaleMedCare is an internet-based healthcare organization specializing in the treatment and care of patients suffering from hormone imbalances due to PMS and menopause. FMC's dedicated scientists, physicians, counselors and support staff are committed to the advancement of a natural approach to hormone replacement therapy - Bio-identical hormone replacement therapy (Bio HRT). Not only can they design a program that will alleviate your symptoms and improve your quality of life, but they can have everything needed delivered right to your door.
FMC's staff of medical doctors and other health care professionals, certified by the Professional Compounding Centers of America, has dedicated their careers to women's health issues with the conviction that solutions to hormonal imbalance may be found in nature.
FemaleMedCare.com has customer service representatives for you to speak to, should you have any questions regarding our services, or with your established account. You may contact us at the telephone numbers below.
Customer Service: 800-928-3134 Doctor Consultations: 800-928-3134 Medical Records Fax: 407-842-7252 CC Authorizations Fax: 407-842-7226
This release was issued through The Xpress Press News Service, merging e- mail and satellite distribution technologies to reach business analysts and media outlets worldwide. For more information, visit http://www.xpresspress.com/
FemaleMedCare, LLC
CONTACT: Jason Greene of FemaleMedCare, LLC, +1-321-206-8409, ext. 2513
Web site: http://www.femalemedcare.com/
Source: PRNewswire
Related Articles
- Lake Hospital System Receives $60,000 Grant for Groundbreaking Music Therapy Study
- Halted Gene Therapy Study to Resume
- FDA Suspends Gene Therapy Study
- Wyeth Seeks Approval for Women's Health Therapies
- BioSante Pharmaceuticals Comments on New Data From Women's Health Initiative Study Showing No Increased Risk of Breast Cancer With Estrogen-Alone Therapy
- ValueOptions and Colorado Health Networks Win Administrative Services Only Contract; Social Security Administration's Mental Health Treatment Study Contract Awarded to Westat With ValueOptions and Colorado Health Networks Serving As ASO
- Effects of Estrogen Replacement Therapy on Pituitary Size, Prolactin and Thyroid-Stimulating Hormone Concentrations in Menopausal Women
- Psychological Effects of Tibolone and Sequential Estrogen- Progestogen Therapy in Perimenopausal Women
- Smoking Reduces Breast Tenderness During Oral Estrogen-Progestogen Therapy
- Visions of Development: A Study of Human Values
 |
 |
User Comments (0)
RSS Feeds